Moreover, PrognoScan analysis revealed a correlation between higher PABPN1 expression and worse survival outcomes in many cancer types, including blood cancer (B-cell lymphoma), lung cancer, breast cancer, bladder cancer, esophagus cancer, brain cancer and colorectal cancer. Here, PABPN1 is linked to lung carcinoma.